Prognostic factors for radiographic damage in early rheumatoid arthritis: A multiparameter prospective study

Arthritis and Rheumatism

Volumn 44, Issue 8, 2001, Pages 1736-1743

  Combe, B ^a,i   Dougados, M ^b   Goupille, P ^c   Cantagrel, A ^d   Eliaou, J F ^e   Sibilia, J ^f   Meyer, O ^g   Sany, J ^a,b   Daures J P ^e   Dubois, A ^a,h  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b Universitaire Cochin ^*  (France)

^c UNIVERSITÉ DE TOURS   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g CENTRE HOSPITALIER   (France)

^h UNIV MONTPELLIER   (France)

ⁱ LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CALPASTATIN; HEAT SHOCK PROTEIN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; KERATIN ANTIBODY; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0034892658     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I     Document Type: Article

References (39)

1. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
2. Long-term outcome of treating rheumatoid arthritis: Results after 20 years
3. Rheumatoid arthritis: Pathogenesis and early recognition
4. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicenter trial
5. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate
6. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
7. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis
8. A prognostic index for erosive changes in the hands, feet and cervical spines in early rheumatoid arthritis
9. Prognosis in rheumatoid arthritis: A longitudinal study of newly diagnosed younger adult patients
10. Prognostic factors and diagnostic criteria in early rheumatoid arthritis
11. Factors predicting outcome of rheumatoid arthritis: Results of a follow-up study
12. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: A prospective follow-up study of 147 patients
13. Prognostic factors in rheumatoid arthritis: Comparative study of two subsets of patients according to severity of articular damage
14. Prognostic factors in rheumatoid arthritis
15. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis
16. Radiographic progression in rheumatoid arthritis: Results of 3 comparative trials
17. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
18. Measurement of patient outcome in arthritis
19. Anti-RA33 antinuclear antibody in rheumatoid arthritis and mixed connective tissue disease: Comparison with antikeratin and antiperinuclear antibodies
20. Anti-heat shock protein 70 and 90 kD antibodies in sera of patients with rheumatoid arthritis
21. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis
22. Statistical methods for assessing agreement between two methods of clinical measurement
23. Smallest detectable difference in radiological progression
24. Combination therapy in early rheumatoid arthritis: A randomized, controlled, double-blind 52 week clinical trial of sulfasalazine and methotrexate versus the single components
25. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification)
26. Disease activity and joint damage progression in early rheumatoid arthritis: Relation to IgG, IgA and IgM rheumatoid factor
27. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy
28. Risk factors for radiographic articular destruction of hands and wrists in rheumatoid arthritis
29. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
30. Association of HLA alleles and clinical features in patients with synovitis of recent onset
31. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years
32. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor
33. Clinical significance of rheumatoid factors in early rheumatoid arthritis: Results of a follow-up study
34. Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritis
35. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis
36. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
37. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
38. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis